Breeding as a means
to select improved plant varieties has benefited
food security for millennia. Breeders rely on a plant species’
genetic diversity to develop new varieties that will meet the changing
agronomic needs of growers, the functional and quality end points
required by food processors and a multitude of end-user demands on
sensory characteristics, convenience, and price. The history of safe
use of crops for food and feed, combined with breeding practices designed
to eliminate plants that do not meet performance or safety standards,
has successfully enabled introduction of new varieties on a continuous
basis. In the United States, the Food and Drug Administration (FDA)
has primary oversight of the safety of all plant-based foods including
those from new plant varieties. In response to the use of recombinant
DNA techniques to introduce modification in plants not possible through
traditional breeding, FDA issued a policy statement in 1992 that outlines
key considerations for safety evaluation of foods derived from new
plant varieties. This includes the history of safe use of the crop
and the donor organism from which any new genetic or protein sequences
are derived and safety assessment of any newly introduced proteins
or changes to the levels of key nutrients or toxins. As understanding
of plant genetics has deepened, new breeding tools have become available.
Genome editing is one of the latest classes of these new breeding
tools that allows plant breeders to target gene loci to create deletions
that inactivate gene(s), make modifications that enhance the function
of a particular gene or move genes within a gene pool, harnessing
existing genetic diversity from within a plant species and its sexually
compatible relatives. FDA’s authority and specific guidance
continues to be relevant for safety assessment of foods derived from
these new plant varieties.